Direct and indirect costs of asthma in Canada, 1990

摘要: OBJECTIVE: To calculate the direct and indirect costs of asthma in Canada. DESIGN: Cost-of-illness study. SETTING: PATIENTS: All Canadians receiving inpatient or outpatient care for 1990. OUTCOME MEASURES: Direct incurred by care, emergency services, physician nursing ambulance use, drugs devices, diagnostic tests, research education. Indirect from productivity loss due to absence work, inability perform housekeeping activities, need children with who were absent school, time spent travelling waiting medical premature death asthma. are 1990 Canadian dollars. RESULTS: Depending on assumptions, total cost was estimated be between $504 million $648 million. $306 The single largest component ($124 million). illness-related disability ($76 CONCLUSIONS: Annual treating comparable individual infectious diseases, hematological congenital defects, perinatal illnesses, home services. Asthma may increase future, given current morbidity mortality trends. Further evaluation effectiveness cost-effectiveness available interventions addition aggregate data required determine whether resource allocation treatment can improved.